Product Description
This digital document is an article from Family Practice News, published by International Medical News Group on October 15, 2004. The length of the article is 732 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Updated guidelines for non-Hodgkin's lymphoma.(Clinical Rounds)
Author: Jeff Evans
Publication: Family Practice News (Magazine/Journal)
Date: October 15, 2004
Publisher: International Medical News Group
Volume: 34Issue: 20Page: 67(1)

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from Worldwide Biotech, published by Worldwide Videotex on December 1, 2008. The length of the article is 1062 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: FDA APPROVES CEPHALON TREANDA TO TREAT NON-HODGKINS LYMPHOMA.
Author: Gale Reference Team
Publication: Worldwide Biotech (Newsletter)
Date: December 1, 2008
Publisher: Worldwide Videotex
Volume: 20Issue: 12Page: NA

Distributed by Gale, a part of Cengage Learning ... Read more

Product Description
Human lymphomas have become of great interest in recent years, because of a dramatic increase in understanding of the different lymphoid cell types giving rise to these tumours, and because modern treatment, involving surgery, radiotherapy, chemotherapy and marrow transplantation, have improved the overall prognosis. Lymphomas also provide insights into the role of oncogenes in cell physiology. Continued improvement in the management of non-Hodgkin's lymphomas is dependent on close collaboration between pathologists, basic scientists and oncologists. The authorship of this book includes clinicians and pathologists and their partnership reflects their professional collaboration. When dealing with genetics, histological methods, normal and abnormal lymph nodes, nodal and extra nodal non-Hodgkin's lymphomas, and modern therapeutics, the authors stress clinical and pathological correlations. An important feature is the emphasis on non-Hodgkin's lymphomas in tissues other than the lymph node. ... Read more

Product Description
This digital document is an article from Transplant News, published by Thomson Gale on August 1, 2007. The length of the article is 494 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Genzyme says phase 3 Mozobil trials meet primary endpoints for treating non-Hodgkin's lymphoma, multiple myeloma.
Author: Gale Reference Team
Publication: Transplant News (Newsletter)
Date: August 1, 2007
Publisher: Thomson Gale
Volume: 17Issue: 8

Distributed by Thomson Gale ... Read more

Product Description
Chapters: Non-Hodgkin Lymphoma, Neurosis, Onan, Lunatic, Idiot, Dementia Praecox, Hysteria, Dysaethesia Aethiopica, Drapetomania, Gay Bowel Syndrome, Moral Insanity, Gay-Related Immune Deficiency, Moron, Imbecile. Source: Wikipedia. Pages: 65. Not illustrated. Free updates online. Purchase includes a free trial membership in the publisher's book club where you can select from more than a million books without charge. Excerpt: Dementia praecox ("premature dementia") refers to a chronic, deteriorating psychotic disorder characterized by rapid cognitive disintegration, usually beginning in the late teens or early adulthood. It is a term first used in 1891 in this Latin form by Arnold Pick (1851-1924), a professor of psychiatry at the German branch of Charles University in Prague. His brief clinical report described the case of a person with a psychotic disorder resembling hebephrenia (see below). It was popularized by German psychiatrist Emil Kraepelin (1856-1926) in 1896 in his first detailed description of a condition that would eventually be reframed and relabeled as schizophrenia. The primary disturbance in dementia praecox is not one of mood (as is the case in manic-depressive illness), but of thinking or cognition. Cognitive disintegration refers to a disruption in cognitive or mental functioning such as in attention, memory, and goal-directed behavior. From the outset, dementia praecox was viewed by Kraepelin as a progressively deteriorating disease from which no one recovered. The three terms that Kraepelin used to refer to the end state of the disease were "verblödung" (deterioration), schwachsinn (mental weakness) or defekt (defect). However, by 1913, and more explicitly by 1920, Kraepelin admitted that although there seemed to be a residual cognitive defect in most cases, the prognosis was not as uniformly dire as he had stated in the 1890s. The term démence précoce was used to describe a psychotic disorder by the Fren...More: http://booksllc.net/?id=9059 ... Read more

Product Description
A comprehensive Guidebook to treatment options and the latest medical advances for Non-Hodgkin's Lymphoma.

The term "lymphoma" is used to describe a variety of cancers that affect the lymphatic system. Lymphomas tend to form solid tumors in the body and are often felt as a painless lump that can occur almost anywhere in the body. The two major types of lymphomas are Hodgkin's Disease and non-Hodgkin's lymphoma.

Non-Hodkin's lymphoma (NHL) is the 6th leading cause of cancer death in the United States. Approximately 95% of cases occur in adults 40 to 70 years in age. The exact cause of NHL is not known and, although a variety of risk factors have been identified, most patients with NHL have no know risk factors.

The most common symptom of NHL is a persistent swelling of lymph nodes anywhere in the body. Other symptoms may include an enlarged liver or spleen, chest pain, shortness of breath, generalized fatigue, drenching night sweats, and loss of appetite.

The treatment options for patients with NHL depend upon a variety of factors including the grade of the lymphoma (low, intermediate, or high); the stage or extent of spread of the disease, the areas of the body affected by the lymphoma, and the general health of the patient. In general, the treatment options range from "watchful waiting" in the earliest stage of the disease to high-dose chemotherapy with stem cell transplantation for patients with aggressive NHL who fail to respond to standard treatment. A variety of new treatments are also currently being investigated.

Learn more by ordering your MediFocus Guidebook on Non-Hodgkin's Lymphoma, the most comprehensive, up-to-date source of information available. You will get answers to your questions, including:

* What are the risk factors of Non-Hodgkin's Lymphoma?
* What standard and alternative treatment options are available?
* Where are the leading doctors, hospitals and medical centers that specialize in Non-Hodgkin's Lymphoma research and treatment?
* What are the results of the latest clinical trials?
* Where are the support groups and additional resources in my area?
* What are the promising new treatments on the horizon?

You won't find this combination of information anywhere else. Your health matters. Don't leave it to chance. Arm yourself with the most comprehensive, up-to-date research available by ordering your MediFocus Guidebook today. ... Read more

Product Description
(Clinical Oncology Advisory Board. The Oncology Group) Georgetown Univ. Hospital, Washington, D.C. Discusses the clinical background, practical considerations, and case studies using ibritumomab tiuxetan therapy. Also covers the past, present, and future uses of this type of therapy in non-hodgkin's lymphoma. Softcover. ... Read more

Product Description
This digital document is an article from Internal Medicine News, published by International Medical News Group on January 1, 2003. The length of the article is 724 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Project aims to track lymphoma outcomes. (Non-Hodgkin's Disease).
Author: Damian McNamara
Publication: Internal Medicine News (Magazine/Journal)
Date: January 1, 2003
Publisher: International Medical News Group
Volume: 36Issue: 1Page: 18(1)

Distributed by Thomson Gale ... Read more